Cargando…

Advances and Prospects in the Treatment of Pancreatic Cancer

Pancreatic cancer is a highly malignant and incurable disease, characterized by its aggressive nature and high fatality rate. The most common type is pancreatic ductal adenocarcinoma (PDAC), which has poor prognosis and high mortality rate. Current treatments for pancreatic cancer mainly encompass s...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Huaiyu, Li, Li, He, Shiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363367/
https://www.ncbi.nlm.nih.gov/pubmed/37489138
http://dx.doi.org/10.2147/IJN.S413496
_version_ 1785076610740781056
author Duan, Huaiyu
Li, Li
He, Shiming
author_facet Duan, Huaiyu
Li, Li
He, Shiming
author_sort Duan, Huaiyu
collection PubMed
description Pancreatic cancer is a highly malignant and incurable disease, characterized by its aggressive nature and high fatality rate. The most common type is pancreatic ductal adenocarcinoma (PDAC), which has poor prognosis and high mortality rate. Current treatments for pancreatic cancer mainly encompass surgery, chemotherapy, radiotherapy, targeted therapy, and combination regimens. However, despite efforts to improve prognosis, and the 5-year survival rate for pancreatic cancer remains very low. Therefore, it’s urgent to explore novel therapeutic approaches. With the rapid development of therapeutic strategies in recent years, new ideas have been provided for treating pancreatic cancer. This review expositions the advancements in nano drug delivery system, molecular targeted drugs, and photo-thermal treatment combined with nanotechnology for pancreatic cancer. It comprehensively analyzes the prospects of combined drug delivery strategies for treating pancreatic cancer, aiming at a deeper understanding of the existing drugs and therapeutic approaches, promoting the development of new therapeutic drugs, and attempting to enhance the therapeutic effect for patients with this disease.
format Online
Article
Text
id pubmed-10363367
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-103633672023-07-24 Advances and Prospects in the Treatment of Pancreatic Cancer Duan, Huaiyu Li, Li He, Shiming Int J Nanomedicine Review Pancreatic cancer is a highly malignant and incurable disease, characterized by its aggressive nature and high fatality rate. The most common type is pancreatic ductal adenocarcinoma (PDAC), which has poor prognosis and high mortality rate. Current treatments for pancreatic cancer mainly encompass surgery, chemotherapy, radiotherapy, targeted therapy, and combination regimens. However, despite efforts to improve prognosis, and the 5-year survival rate for pancreatic cancer remains very low. Therefore, it’s urgent to explore novel therapeutic approaches. With the rapid development of therapeutic strategies in recent years, new ideas have been provided for treating pancreatic cancer. This review expositions the advancements in nano drug delivery system, molecular targeted drugs, and photo-thermal treatment combined with nanotechnology for pancreatic cancer. It comprehensively analyzes the prospects of combined drug delivery strategies for treating pancreatic cancer, aiming at a deeper understanding of the existing drugs and therapeutic approaches, promoting the development of new therapeutic drugs, and attempting to enhance the therapeutic effect for patients with this disease. Dove 2023-07-19 /pmc/articles/PMC10363367/ /pubmed/37489138 http://dx.doi.org/10.2147/IJN.S413496 Text en © 2023 Duan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Duan, Huaiyu
Li, Li
He, Shiming
Advances and Prospects in the Treatment of Pancreatic Cancer
title Advances and Prospects in the Treatment of Pancreatic Cancer
title_full Advances and Prospects in the Treatment of Pancreatic Cancer
title_fullStr Advances and Prospects in the Treatment of Pancreatic Cancer
title_full_unstemmed Advances and Prospects in the Treatment of Pancreatic Cancer
title_short Advances and Prospects in the Treatment of Pancreatic Cancer
title_sort advances and prospects in the treatment of pancreatic cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363367/
https://www.ncbi.nlm.nih.gov/pubmed/37489138
http://dx.doi.org/10.2147/IJN.S413496
work_keys_str_mv AT duanhuaiyu advancesandprospectsinthetreatmentofpancreaticcancer
AT lili advancesandprospectsinthetreatmentofpancreaticcancer
AT heshiming advancesandprospectsinthetreatmentofpancreaticcancer